Patent details
EP1578439 Title: LOW DOSE METHODS FOR TREATING DISORDERS IN WHICH TNF-ALPHA ACTIVITY IS DETRIMENTAL
Basic Information
- Publication number:
- EP1578439
- PCT Application Number:
- PCT/US/2003/033973
- Type:
- European Patent Granted for LU
- Legal Status:
- Lapsed
- Application number:
- EP038096442
- PCT Publication Number:
- WO/2004/037205
- First applicant's nationality:
- Translation Language:
- EPO Publication Language:
- English
- English Title of Invention:
- LOW DOSE METHODS FOR TREATING DISORDERS IN WHICH TNF-ALPHA ACTIVITY IS DETRIMENTAL
- French Title of Invention:
- THERAPIES FAIBLEMENT DOSEES POUR TRAITER DES TROUBLES POUR LESQUELS L'ACTIVITE DES FACTEURS DE NECROSE TUMORALE ALPHA EST PREJUDICIABLE
- German Title of Invention:
- NIEDRIGDOSIERTE VERFAHREN ZUR BEHANDLUNG VON ERKRANKUNGEN, BEI DENEN TNF-ALPHA-AKTIVITÄT SCHÄDLICH IST
- SPC Number:
Dates
- Filing date:
- 24/10/2003
- Grant date:
- 27/07/2011
- EP Publication Date:
- 27/07/2011
- PCT Publication Date:
- 06/05/2004
- Claims Translation Received Date:
- Translations Received Date (B1 EP Publication):
- Translations Received Date (B2 EP Publication):
- Translations Received Date (B3 EP Publication):
- Publication date:
- 28/09/2005
- EP B1 Publication Date:
- 27/07/2011
- EP B2 Publication Date:
- EP B3 Publication Date:
- Lapsed date:
- 24/10/2017
- Expiration date:
- 24/10/2023
- Renunciation date:
- Revocation date:
- Annulment date:
Owner
- From:
- 01/04/2014
- Name:
- ABBVIE BIOTECHNOLOGY LTD
- Address:
- CLARENDON HOUSE, 2 CHURCH STREET, HAMILTON HM11, Bermuda (BM)
History of Owners
- From:
- 24/10/2003
- To:
- 31/03/2014
- Name:
- Abbott Biotechnology Ltd
- Address:
- Clarendon House, 2 Church Street, HM 11 Hamilton, Bermuda (BM)
Agent
- Name:
- OFFICE FREYLINGER S.A.
- From:
- 26/10/2011
- Address:
- Boîte Postale 48, L-8001, STRASSEN, Luxembourg (LU)
- To:
Inventor
1
- Name:
- KAYMAKCALAN Zehra
- Address:
- United States (US)
2
- Name:
- KAMEN Robert
- Address:
- United States (US)
Priority
- Priority Number:
- 421262 P
- Priority Date:
- 24/10/2002
- Priority Country:
- United States (US)
Classification
- Main IPC Class:
- A61K 38/19;
Annual Fees
- Annual Fee Due Date:
- Annual Fee Number:
- Expected Payer:
- Last Annual Fee Payment Date:
- 20/10/2016
- Last Annual Fee Paid Number:
- 14
- Last Annual Fee Paid Amount:
- 198 Euro
- Payer:
- MDC (HENKEL PATENT)
| Filing date | Document type | Number of pages |
|---|